Offline
Multidisciplinary

Tumor board & case conferences

Coordinate complex cases across oncology, surgery, radiology, and pathology with shared evidence and structured recommendations.

Cases this week
14
Avg participants
9
Next session
Thu 7:30a
Recs documented
98%

Upcoming cases

  • MRN 8821 · 58F — Stage II breast invasive ductal
    Dr. Okafor (Med Onc) · Thu 7:30a
    on agenda
  • MRN 9104 · 71M — T3N1 rectal adeno
    Dr. Liu (Surg Onc) · Thu 7:45a
    on agenda
  • MRN 7732 · 44F — Recurrent papillary thyroid
    Dr. Patel (Endo) · Thu 8:00a
    on agenda
  • MRN 6650 · 63M — NSCLC, EGFR exon 19
    Dr. Reyes (Med Onc) · Thu 8:15a
    on agenda

Pre-read packet

  • Pathology slides + reportattached
  • Cross-sectional imaging (PACS)attached
  • Molecular & NGS panelattached
  • Prior treatment timelineattached
  • Trial eligibility (matched)attached

Documented consensus

  • Recommend neoadjuvant chemo → re-stage at 12 wks
  • Refer to GU oncology for second opinion
  • Enroll in CARTER-LUNG-04 if eligible